Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Malaysia Consults On Medical Device Risk Classifications

Executive Summary

A 20-day consultation on the risk classification of medical devices intended for the Malaysia market ends on 28 February

You may also be interested in...



Global Medtech Guidance Tracker: February 2022

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Thirty-six documents have been posted on the tracker since its last update.

Malaysia finalises medtech regs to support new mandatory framework from 1 July

The Malaysian government has finalised its much-awaited medical device regulations, paving the way for the implementation of new mandatory requirements from 1 July 2013.

NICE: Real-World Evidence Revolution Will Drive UK’s Health Care Innovation

In its just-released real-world evidence framework, NICE assesses the role and value of data collected outside highly-controlled clinical studies in driving more innovation towards health care professionals.

Topics

Latest News
UsernamePublicRestriction

Register

MT145109

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel